RAPAMUNE
Glenmark Pharma gets USFDA nod for generic drugThe company's US-based subsidiary has received final approval from the US Food and Drug Administration (USFDA) for the product which is a g...
Dr Reddy's launches generic version of Rapamune tablets in USAccording to IMS Health sales data, the Rapamune brand had sales of $206 million in the US market for 12 months ended August 2014, it added.- Mylan sells stake in Concord BiotechWorld’s second-largest generic drug maker Mylan, which held a majority stake in Ahmedabad-based Concord Biotech through its subsidiary Matr...
- Load More